Pharma Talk
Get recent Updates in Pharma Industry
(Move to ...)
Home
▼
Sunday, April 6, 2025
Validation Master Plan and Validation Protocols Correlated
›
The FDA found that although there were requirements in the Validation Master Plan for process validation and hold times, no operating condit...
Sunday, March 23, 2025
WHO: Updates on Method Transfer
›
In 2022, the WHO published the "Technical Report Series 1044, 2022" called "TRS 1044 - Annex 4: WHO guidelines on technology ...
Root Cause Analysis and FDA WL
›
Your firm failed to conduct adequate manufacturing investigations into out-of-specification (OOS) results obtained by your external laborato...
Cleaning Validation and FDA WL
›
SOPs on Cleaning Validation not followed The FDA criticizes that the cleaning validation for non-dedicated equipment and its maintenance are...
Warning Letter - Deficiencies in the Control of Raw and Starting Materials
›
The FDA has investigated the hi u need it ugtygsyjthz yubsybh fhgjeg bb manufacturiyng practices of Shantou Kangjie Daily Chemical Industry ...
No further Extension of GDP Certificates in 2025 by EMA
›
Background During the COVID-19 pandemic, various exemptions were introduced for GDP inspections as well as for the validity and extension of...
Guidance Documents on Variation Notifications Updated
›
On the website of the HMA (Heads of Medicines Agencies), under the heading "Variations", you will find the "Guidance Document...
New Guidance for Industry draft on AI by FDA
›
In January 2025, the U.S. Food and Drug Administration (FDA) published a draft Guidance for Industry and other interested parties entitled ...
Monday, March 3, 2025
Tyche Industries Ltd — February 06, 2025
›
Failure to record all quality-related activities at the time they are performed. Your quality unit (QU) failed to ensure the integrity of CG...
Wednesday, February 26, 2025
Vendor CoA based approval and FDA 483
›
Insufficient monitoring was carried out to ensure that the system was functioning properly and was suitable for production. FDA requirements...
‹
›
Home
View web version